基本信息
views: 14
Career Trajectory
Bio
Research
Genetic discovery: Adam’s main interests revolve around the identification of genetic variation linked with coronary disease, related phenotypes (eg, vascular risk factors such as lipids) and molecular ‘omics (eg, plasma proteomics and metabolomics) using SNP arrays. Current efforts in this area include the CARDIoGRAMplusC4D 1M+ Hearts project, the 100,000 participant CHD Exome+ consortium and imputed GWAS studies in INTERVAL and UK Biobank.
Human genetics to inform therapeutics: By relating informative genetic variants (eg, variants of known function) to disease outcomes and phenotypes, inference about the likely efficacy and safety profile of therapeutic agents (or potential therapeutic agents) can be made. For example, the work of Adam and colleagues at CEU has highlighted the relationship of IL6R variants to risk of heart disease, raising the possibility of monoclonal antibodies being repurposed from inflammatory conditions to cardiovascular pathways. Adam works closely with large pharmaceutical companies to help discover and evaluate pathways of potential therapeutic interest.
EPIC-CVD: Adam is the Scientific Coordinator of the EPIC-Heart/EPIC-CVD study, which is a pan-European study of incident coronary disease and stroke including participants from 23 centres across 10 European countries. This project has a wealth of genetic, biochemical and risk factor data, which are predominantly utilised for the study of gene-environment interaction, cardiovascular risk prediction, and genetic discovery.
Genetic discovery: Adam’s main interests revolve around the identification of genetic variation linked with coronary disease, related phenotypes (eg, vascular risk factors such as lipids) and molecular ‘omics (eg, plasma proteomics and metabolomics) using SNP arrays. Current efforts in this area include the CARDIoGRAMplusC4D 1M+ Hearts project, the 100,000 participant CHD Exome+ consortium and imputed GWAS studies in INTERVAL and UK Biobank.
Human genetics to inform therapeutics: By relating informative genetic variants (eg, variants of known function) to disease outcomes and phenotypes, inference about the likely efficacy and safety profile of therapeutic agents (or potential therapeutic agents) can be made. For example, the work of Adam and colleagues at CEU has highlighted the relationship of IL6R variants to risk of heart disease, raising the possibility of monoclonal antibodies being repurposed from inflammatory conditions to cardiovascular pathways. Adam works closely with large pharmaceutical companies to help discover and evaluate pathways of potential therapeutic interest.
EPIC-CVD: Adam is the Scientific Coordinator of the EPIC-Heart/EPIC-CVD study, which is a pan-European study of incident coronary disease and stroke including participants from 23 centres across 10 European countries. This project has a wealth of genetic, biochemical and risk factor data, which are predominantly utilised for the study of gene-environment interaction, cardiovascular risk prediction, and genetic discovery.
Research Interests
Papers共 307 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Emanuele Osimo, Kaijia Zhang, Benjamin Chidiac, Vivian Zhao, Suleyman Noordeen,Varun Warrier,Adam Butterworth,Benjamin Perry,Graham Murray
crossref(2024)
Barbara Schormair, Chen Zhao,Steven Bell,Maria Didriksen, Muhammad S Nawaz, Nathalie Schandra,Ambra Stefani,Birgit Högl,Yves Dauvilliers,Cornelius G Bachmann,David Kemlink,Karel Sonka,
Nature genetics (2024)
Stefan Gustafsson,Erik Lampa, Karin Jensevik Eriksson,Adam S. Butterworth,Sölve Elmståhl,Gunnar Engström,Kristian Hveem,Mattias Johansson,Arnulf Langhammer,Lars Lind,Kristi Läll, Giovanna Masala,
Jingjing Zhu,Ke Wu, Shuai Liu, Alexandra Masca, Hua Zhong, Tai Yang,Dalia H Ghoneim,Praveen Surendran, Tanxin Liu,Qizhi Yao,Tao Liu,Sarah Fahle,
GigaScienceno. 6_Supplement (2024): 6153-6153
Alzheimer's Research & Therapyno. 1 (2024): 8-8
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn